Exagen Inc. (XGN)

Exagen had revenue of $15.50M in the quarter ending March 31, 2025, with 7.51% growth. This brings the company's revenue in the last twelve months to $56.72M, up 1.78% year-over-year. In the year 2024, Exagen had annual revenue of $55.64M with 5.89% growth.

• Revenue (ttm): $56.72M
• Revenue Growth: +1.78%
• P/S Ratio: 2.26
• Revenue / Employee: $263,833
• Employees: 215
• Market Cap: 152.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	55.64M	3.09M	5.89%
Dec 31, 2023	52.55M	6.99M	15.33%
Dec 31, 2022	45.56M	-2.74M	-5.66%
Dec 31, 2021	48.30M	6.32M	15.07%
Dec 31, 2020	41.98M	1.59M	3.93%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.